NDUFA4L2 reportedly acts as an oncogene; notably, it is a direct transcriptional target of HIF-1α in hepatocellular carcinoma, clear cell renal cell carcinoma, lung cancer, and colorectal cancer6,8,9. Here, COXFA4L2 is linked to lung carcinoma.